Skye Bioscience Inc hires CMAX to run its phase 1 study of lead candidate SBI-100 OE for glaucoma

Skye Bioscience inc (OTCQB:SKYE) said it has hired experienced Australian clinical trial operator CMAX to run its phase 1 study of lead candidate SBI-100 OE...

Related Keywords

Australia ,Adelaide ,South Australia ,Australian ,Skye Bioscience ,Tu Diep ,Australian Therapeutics Goods Administration ,Human Research Ethics Committee ,Professor Shakib ,Clinical Trial Notification ,